These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15117822)

  • 1. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface.
    Davis FB; Mousa SA; O'Connor L; Mohamed S; Lin HY; Cao HJ; Davis PJ
    Circ Res; 2004 Jun; 94(11):1500-6. PubMed ID: 15117822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-angiogenesis action of thyroid hormone and analogs in a three-dimensional in vitro microvascular endothelial sprouting model.
    Mousa SA; Davis FB; Mohamed S; Davis PJ; Feng X
    Int Angiol; 2006 Dec; 25(4):407-13. PubMed ID: 17164749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
    Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
    Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The proangiogenic action of thyroid hormone analogue GC-1 is initiated at an integrin.
    Mousa SA; O'Connor LJ; Bergh JJ; Davis FB; Scanlan TS; Davis PJ
    J Cardiovasc Pharmacol; 2005 Sep; 46(3):356-60. PubMed ID: 16116342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proangiogenesis action of the thyroid hormone analog 3,5-diiodothyropropionic acid (DITPA) is initiated at the cell surface and is integrin mediated.
    Mousa SA; O'Connor L; Davis FB; Davis PJ
    Endocrinology; 2006 Apr; 147(4):1602-7. PubMed ID: 16384862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway.
    Liu X; Zheng N; Shi YN; Yuan J; Li L
    J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid hormone and angiogenesis.
    Luidens MK; Mousa SA; Davis FB; Lin HY; Davis PJ
    Vascul Pharmacol; 2010; 52(3-4):142-5. PubMed ID: 19879961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.
    Yalcin M; Bharali DJ; Lansing L; Dyskin E; Mousa SS; Hercbergs A; Davis FB; Davis PJ; Mousa SA
    Anticancer Res; 2009 Oct; 29(10):3825-31. PubMed ID: 19846915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process.
    Presta M; Rusnati M; Belleri M; Morbidelli L; Ziche M; Ribatti D
    Cancer Res; 1999 May; 59(10):2417-24. PubMed ID: 10344752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor-2 mediates Angiotensin-converting enzyme inhibitor-induced angiogenesis in coronary endothelium.
    Donnini S; Solito R; Giachetti A; Granger HJ; Ziche M; Morbidelli L
    J Pharmacol Exp Ther; 2006 Nov; 319(2):515-22. PubMed ID: 16868034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of fibroblast growth factor-2 isoforms in the effect of estradiol on endothelial cell migration and proliferation.
    Garmy-Susini B; Delmas E; Gourdy P; Zhou M; Bossard C; Bugler B; Bayard F; Krust A; Prats AC; Doetschman T; Prats H; Arnal JF
    Circ Res; 2004 May; 94(10):1301-9. PubMed ID: 15073041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo.
    Uchiba M; Okajima K; Oike Y; Ito Y; Fukudome K; Isobe H; Suda T
    Circ Res; 2004 Jul; 95(1):34-41. PubMed ID: 15166095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone stimulation of extracellular signal-regulated kinase and cell proliferation in human osteoblast-like cells is initiated at integrin alphaVbeta3.
    Scarlett A; Parsons MP; Hanson PL; Sidhu KK; Milligan TP; Burrin JM
    J Endocrinol; 2008 Mar; 196(3):509-17. PubMed ID: 18310446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of expression of LDH isoenzymes in endothelial cells by laminin: implications for angiogenesis.
    Kumar VB; Viji RI; Kiran MS; Sudhakaran PR
    J Cell Biochem; 2008 Apr; 103(6):1808-25. PubMed ID: 18092337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells.
    Dell'Era P; Belleri M; Stabile H; Massardi ML; Ribatti D; Presta M
    Oncogene; 2001 May; 20(21):2655-63. PubMed ID: 11420677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
    Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
    Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid hormone analogues potentiate the antiviral action of interferon-gamma by two mechanisms.
    Lin HY; Thacore HR; Davis FB; Davis PJ
    J Cell Physiol; 1996 May; 167(2):269-76. PubMed ID: 8613467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
    Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
    J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2.
    Ribatti D; Gualandris A; Belleri M; Massardi L; Nico B; Rusnati M; Dell'Era P; Vacca A; Roncali L; Presta M
    J Pathol; 1999 Dec; 189(4):590-9. PubMed ID: 10629563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.